Ralph Meyer Phase III Program Young Investigator Award

The Ralph Meyer Phase III Program Young Investigator Award has been awarded to Dr. Rachel Glicksman from Princess Margaret Cancer Centre recognizing her active participation and enrollment activities as a young investigation in CCTG trials. This award is presented to individuals who have made significant contributions to the phase III program research projects.

Rachel acknowledged, "I am honored to receive the CCTG 2025 Ralph Meyer Phase III Young Investigator Award. I am grateful for this recognition and excited about the opportunity to contribute to the ongoing advancements in cancer care through CCTG with wonderful colleagues."

Dr. Rachel Glicksman is a Radiation Oncologist at Princess Margaret Cancer Centre, University Health Network, and an Assistant Professor in the Department of Radiation Oncology at University of Toronto. She is a graduate of Queen’s University and completed her Radiation Oncology residency and Fellowship at the University of Toronto in 2020. Her clinical and research focus is in the management of genitourinary and breast cancers, and oligometastatic disease. 

Rachel has been an active participant in CCTG trials since 2021 including: GCC.1 (SI), PR.19 (QI), and PR 24(QI). Her enrollment activity ranks within the top 10 for both PR.19 and PR.24 and she is a member of the PR.24 trial committee.